Steve Martin is now serving in a new board position at Ensysce Biosciences, Inc.
Sep 13, 2020
Board and Executive Moves
Chief Financial Officer & Principal Accounting Officer at Armata Pharmaceuticals, Inc.
In The News
-Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Results and Provides General Corporate Update
Mar 19, 2021 - ENP Newswire
Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Results and Provides General Corporate Update
Mar 18, 2021 - PR Newswire
Ensysce Biosciences, Inc. supplies drugs for pain and cancer markets. Its technologies include opioid drug abuse-resistant, single-walled carbon nanotubes, SWCNT-immuno and gene therapy and BIO-MD prodrug technology. The company was founded by Bob G. Gower and William H.C. Chang in 2008 and is headquartered in San Diego, CA.
In The News
Ensysce Biosciences, Inc. And Leisure Acquisition Corp. Announce Appointment Of Dave Humphrey As Chief Financial Officer
Feb 18, 2021 - PR Newswire
Ensysce Biosciences, a California Based Biotech With a Mission to Solve the Opioid Crisis, Secures $60 Million Capital Commitment From Global Emerging Markets; Ensysce revolutionizing analgesia: tackling the biggest crises in US healthcare.
Dec 31, 2020 - Business Wire